INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)

Instituto

Foto de INSTITUTO DE BIOMEDICINA Y GENÉTICA MOLECULAR (IBGM)

Foto de Massachusetts Institute of Technology

Massachusetts Institute of Technology

Cambridge, Estados Unidos

Publicaciones en colaboración con investigadores/as de Massachusetts Institute of Technology (8)

2022

Publisher Correction: Stroke genetics informs drug discovery and risk prediction across ancestries (Nature, (2022), 611, 7934, (115-123), 10.1038/s41586-022-05165-3)
Nature
Stroke genetics informs drug discovery and risk prediction across ancestries
Nature, Vol. 611, Núm. 7934, pp. 115-123

2019

Author Correction: Crizotinib-induced immunogenic cell death in non-small cell lung cancer (Nature Communications, (2019), 10, 1, (1486), 10.1038/s41467-019-09415-3)
Nature Communications
Crizotinib-induced immunogenic cell death in non-small cell lung cancer
Nature Communications, Vol. 10, Núm. 1

2016

Role of FAST kinase domains 3 (FASTKD3) in post-transcriptional regulation of mitochondrial gene expression
Journal of Biological Chemistry, Vol. 291, Núm. 50, pp. 25877-25887

2013

Coreceptor affinity for MHC defines peptide specificity requirements for TCR interaction with coagonist peptide-MHC
Journal of Experimental Medicine, Vol. 210, Núm. 9, pp. 1807-1821
MICU1 controls both the threshold and cooperative activation of the mitochondrial Ca2+ uniporter
Cell Metabolism, Vol. 17, Núm. 6, pp. 976-987

2010

Common genetic variants and modification of penetrance of BRCA2-associated breast cancer
PLoS Genetics, Vol. 6, Núm. 10, pp. 1-12